The Associated Press
U.S. sales levels for many widely used drug categories shifted significantly in 2012, with sales in some classes declining sharply due to an infusion of cheaper new generic pills. Other categories grew, mainly with the introduction of new, generally expensive medicines.
Here's a look at U.S. sales of the top-grossing drug categories in 2012:
DRUG CATEGORY 2012 spending Change from 2011
Cancer medicines $25.9 billion Up 7.8 percent
Mental illness $23.5 billion Down 21 percent
Respiratory disorders $22.1 billion Up 1.9 percent
Diabetes medicines $22 billion Up 7.1 percent
Painkillers $18.2 billion Up 1.6 percent
Cholesterol/lipid drugs $16.9 billion Down 20.6 percent
Immune disorders $14.8 billion Up 17.9 percent
High blood pressure $13.6 billion Down 3 percent
HIV/AIDS medicines $11.7 billion Up 12.1 percent
Attention deficit disorder $10.4 billion Up 13.1 percent
Ulcer medicines $10 billion Down 4.7 percent
Multiple sclerosis drugs $8.9 billion Up 17.8 percent
Antibiotics $7.9 billion Down 14.8 percent
Nervous system disorders $7.2 billion up 3.7 percent
Vaccines $6.8 billion Up 7.2 percent
Source: IMS Institute for Healthcare Informatics.
Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.